Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study

Hormone Research

Volumn 49, Issue 6, 1998, Pages 269-278

  Juul, Anders ^a,d   Andersson, Anna Maria ^a   Pedersen, Søren A ^a   Jørgensen, Jens Otto L ^b   Christiansen, Jens Sandahl ^b   Groome, Nigel P ^c   Skakkebæk, Niels E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d Rigshospitalet   (Denmark)

Author keywords

Androgens; GH replacement therapy; GH deficient adults; GNRH test; hCG test; Inhibin B; Prostate specific antigen; Semen quality; Sex hormone binding globulin

Indexed keywords

FOLLITROPIN; GONADORELIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; PLACEBO; PRASTERONE SULFATE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS GONAD SYSTEM; MALE; MALE GENITAL SYSTEM; ONSET AGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION;

ADRENOCORTICOTROPIC HORMONE; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTRADIOL; FOLLICLE STIMULATING HORMONE; GLUTAMATE CARBOXYPEPTIDASE II; GONADOTROPIN-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MALE; PEPTIDES; PITUITARY GLAND; PROSTATIC SECRETORY PROTEINS; SEX HORMONE-BINDING GLOBULIN; SPERM COUNT; TESTIS; TESTOSTERONE;

EID: 0031798783     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023186     Document Type: Article

References (51)

1. Balducci R, Toscane V, Mangiantini A, Bianchi P, Guglielmi R, Boscherini B: The effect of growth hormone administration on testicular response during gonadotropin therapy in subjects with combined gonadotropin and growth hormone deficiencies. Acta Endocrinol 1993; 128:19-23.
2. Kulin HE, Samojlik E, Santen R, Santner S: The effect of growth hormone in the Leydig cell response to chorionic gonadotrophin in boys with hypopituitarism. Clin Endocrinol 1981; 15:463-472.
3. Laron Z, Mimouni F, Pertzelan A: Effect of human growth hormone therapy on penile and testicular size in boys with isolated growth hormone deficiency: First year of treatment. Isr J Med Sci 1983;19:338-344.
4. Laron Z, Sarel R: Penis and testicular size in patients with growth hormone insufficiency. Acta Endocrinol 1970;63:625-633.
5. Savage MO, Blum WF, Ranke MB, et al: Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993;77: 1465-1471.
6. Darendeliler F, Hindmarsh PC, Preece MA, Cox L, Brook CGD: Growth hormone increases rate of pubertal maturation. Acta Endocrinol 1990;122:414-416.
7. Stanhope R, Albanese A, Hindmarsh P, Brook CGD: The effects of growth hormone therapy on spontaneous sexual development. Horm Res 1992;38(suppl 1):9-13.
8. Zachmann M, Prader A: Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. J Clin Endocrinol 1970;40:85-95.
9. Aynsley-Green A, Zachmann M, Prader A: Interrelation of the therapeutic effects of growth hormone and testosterone on growth in hypopituitarism. J Pediatr 1976;89:992-999.
10. Pedersen SA, Jørgensen JO, Christiansen JS, Jensen S, Jelnæ JE, Skakkebæk NE: Growth hormone and reproduction: Reduced semen quality in men previously treated for growth hormone deficiency; in Frisch H, Thorner MO (eds): Hormonal Regulation of Growth. New York, Raven Press, 1989, pp 273-282.
11. Okada Y, Kondo T, Okamoto S, Ogawa M: Induction of ovulation and spermatogenesis by hMG/hCG in hypogonadotropic GH-deficient patients. Endocrinol Jpn 1992;39:31-43.
12. Gregory JW, Greene SA, Thompson J, Rennie MJ: Effects of oral testosterone undecanoate on growth, body composition, strength, and energy expenditure of adolescent boys. Clin Endocrinol 1992;37:207-213.
13. Bhansin S, Storer TW, Berman N, et al: Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82:407-413.
14. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM: Estrogen replacement therapy I: A ten-year prospective study on the relationship to osteoporosis. Obstet Gynecol 1979;53: 277-281.
15. Jørgensen JOL, Pedersen SA, Thuesen L, et al: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;i:1221-1225.
16. Juul A, Pedersen SA, Sørensen S, et al: Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in adults with GH-deficiency of childhood onset. Eur J Endocrinol 1994;131:41-49.
17. Juul A, Bang P, Hertel NT, et al: Serum insulin-like growth factor-1 in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
18. Juul A, Holm K, Kastrup KW, et al: Free insulin-like growth factor (IGF)-I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone-deficiency. J Clin Endocrinol Metab 1997;82:2497-2502.
19. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-1298.
20. Groome NP, Illingworth PJ, O'Brien M, et al: Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405.
21. Parker CRJ, Ellegood JO, Mahesh VB: Methods for multiple steroid radioimmunoassay. J Steroid Biochem 1975;6:1-8.
22. Bartsch W: Interrelationships between sex-hormone-binding globulin and testosterone. 5-a-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas 1980;2:109-118.
23. Juul A, Müller J, Skakkebæk NE: Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment. Eur J Endocrinol 1997;136:401-405.
24. World Health Organization: Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Geneva, World Health Organization, 1980.
25. Giustina A, Scalvini T, Tassi C, et al: Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab 1997;82:1210-1219.
26. Metzger DL, Kerrigan JR: Androgen receptor blockade with flutamide enhances growth hormone secretion in late pubertal males: Evidence for independent actions of estrogen and androgen. J Clin Endocrinol Metab 1993;76: 1147-1152.
27. Metzger DL, Kerrigan JR: Estrogen blockade with tamoxifen diminishes growth hormone secretion in boys: Evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab 1994;79:513-518.
28. Illingworth PJ, Groome NP, Byrd W, et al: Inhibin-B: A likely candidate for the physiologically important form of Inhibin in men. J Clin Endocrinol Metab 1996;81:1321-1325.
29. Anawalt BD, Bebb RA, Matsumoto AM, et al: Serum inhibin levels reflect sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81: 3341-3345.
30. McLachlan RI, Finkel DM, Bremner WJ, Snyder PJ: Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: Physiological and clinical implications. J Clin Endocrinol Metab 1990;70:1414-1419.
31. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJP, Hill DJ: Differential cellular synthesis of Insulin-like Growth Factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994;79: 1871-1876.
32. Skjærbæk C, Frystyk J, Møller J, Christiansen JS, Ørskov H: Free and total insulin-like growth factor and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults. Eur J Endocrinol 1996;135:672-677.
33. De Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E: Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996;81:1371-1377.
34. Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd I-L, Hall K: Serum insulin-like growth factor I (IGF-I), IGF-binding proteins-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1997; 82:223-228.
35. Moustari M, Terraza A, Lobaccaro JM, Sultan C: Action of IGF-I on 5 alpha- reductase activity in genital skin fibroblasts (abstract 40). Horm Res 1992;37:11.
36. Skakkebæk NE, Bancroft J, Davidson DW, Warner P: Androgen replacement with oral testosterone undecanoate in hypogonadal men: A double blind controlled study. Clin Endocrinol 1981;14:49-61.
37. Belgorosky A, Martinez A, Domene H, Heinrich JJ, Bergada C, Rivarola MA: High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: Effect of recombinant human growth hormone treatment. J Clin Endocrinol Metab 1987;65:1107-111.
38. Gafny M, Silbergeld A, Klinger B, Wasserman M, Laron Z: Comparative effects of GH, IGF-I and insulin on sex hormone binding globulin. Clin Endocrinol 1994;41:169-175.
39. Anapliotou MGL, Evagellou E, Kastanias I, Liparaki M, Psara P, Goulandris N: Effect of growth hormone cotreatment with human chorionic gonadotropin in testicular steroidogenesis and seminal insulin-like growth factor-1 in oligozoospermia. Fertil Steril 1996;66:305-311.
40. Sauder SE, Corley KP, Hopwood NJ, Kelch RP: Subnormal gonadotropin resonse to gonadotropin releasing hormone persist into puberty in children with isolated growth hormone deficiency. J Clin Endocrinol Metab 1981;53: 1186-1192.
41. Kelch RP, Markovs M, Huss J: LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: Lacks of effect of replacement therapy with human growth hormone. J Clin Endocrinol Metab 1976;42:1104-1113.
42. Sklar CA, Ulmstrom RA: Effect of human growth hormone on adrenal androgens in children with growth hormone deficiency. Horm Res 1984;20:166-171.
43. Castro-Magana M, Maddaiah VT, Collipp PJ, Angulo M: Synergistic effects of growth hormone therapy on plasma levels of 11-deoxycortisol and cortisol in growth hormone-deficient children. J Clin Endocrinol Metab 1983;56: 662-667.
44. Weinstein R, Kelch R, Jenner M: Secretion of androgens and estrogens by the normal and abnormal human testis. J Clin Invest 1974;53: 1-7.
45. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER: Androgen-stimulated pubertal growth: The effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 1993;76:996-1001.
46. Stamey TA, Kabalin JN, Ferrari M, Yang N: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients. J Urol 1989;141:1088-1090.
47. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS, Plymate SR: Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 1996;81:3774-3782.
48. Tennant MK, Thrasher JB, Twomey PA, Birnbaum RS, Plymate SR: Insulin-like growth factor-binding proteins (IGFBP)-4, -5 and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J Clin Endocrinol Metab 1996;81:3783-3792.
49. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG: Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75: 1046-1053.
50. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D: Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol 1993;39:417-425.
51. Blok GJ, De Boer H, Gooren LJG, Van der Veen EA: Growth hormone substitution in adults growth hormone-deficient men augment androgen effects on the skin. Clin Endocrinol 1997;47:36.